References
- O'Brien W. F. Predicting Preeclampsia. Obstet. Gynaecol. 1990; 75: 445–452
- Friedman S. A., de Groot C. J.M., Taylor R. N., Golditch B. D., Roberts J. M. Plasma Cellular Fibronectin as a Measure of Endothelial Involvement in Preeclampsia and Intrauterine Growth Retardation. Am. J. Obstet. Gynecol. 1994; 170(3)838–841
- Romberger D. J. Molecules in Focus. Int. J. Biochem. Cell. Biol. 1997; 29: 939–943
- Lockwood C. J., Peters J. H. Increased Plasma Levels of ED1+ Cellular Fibronectin Precede the Clinical Signs of Preeclampsia. Am. J. Obstet. Gynecol. 1990; 162(2)358–362
- Davey D. A., Mac Gillivray I. The Classification and Definition of the Hypertensive Disorders of Pregnancy. Am. J. Obstet. Gynecol. 1988; 158: 892–898
- Marsal K., Persson P.-H., Larsen T., Lilja H., Selbing A., Sultan B. Intrauterine Growth Curves Based on Ultrasonically Estimated Foetal Weights. Acta Paediatr. 1996; 85: 843–848
- Sternberg J. C. A Rate Nephelometer for Measuring Specific Proteins by Immunoprecipitin Reactions. Clin. Chem. 1997; 23(8)1456–1464
- Eriksen H. O., Hansen P. K., Brocks V., Jensen B. A. Plasma Fibronectin Concentration in Normal Pregnancy and Preeclampsia. Acta Obstet. Gynecol. Scand. 1987; 66: 25–28
- Sakura M., Nakabayashi M., Takeda Y., Sato K. Elevated Fetal Fibronectin in Midtrimester Amniotic Fluid Is Involved with the Onset of Preeclampsia. J. Obstet. Gynaecol. Res. 1998; 24(1)73–76
- Jones I., Cowley D., Andersen M., Vacca A., Voroteleiak V. Fibronectin as a Predictor of Preeclampsia: A Pilot Study. Obstet. Gynaecol. 1996; 36: 1–3
- Gredmark T., Bergman B., Hellstrom L. Total Fibronectin in Maternal Plasma as a Predictor for Preeclampsia. Gynecol. Obstet. Invest. 1999; 47(2)89–94
- Ballegeer V., Spitz B., Kieckens L., Moreau H., Van Assche A., Collen D. Predictive Value of Increased Plasma Levels of Fibronectin in Gestational Hypertension. Am. J. Obstet. Gynecol. 1989; 161(2)432–436
- Sud S. S., Gupta I., Dhaliwal L. K., Kaur B., Ganguly N. K. Serial Plasma Fibronectin Levels in Preeclamptic and Normotensive Women. Int. J, Gynaecol. Obstet. 1999; 66(2)123–128
- Dreyfus M., Baldauf J.-J., Ritter J., Van Cauwenberg J.-R., Hardy A., Foidart J.-M. The Prediction of Preeclampsia: Reassessment of Clinical Value of Increased Plasma Levels of Fibronectin. Eur. J. Obst. Gynecol. Reprod. Biol. 1998; 78: 25–28
- Halligan A., Bonnar J., Sheppard B., Darling M., Walshe J. Haemostatic, Fibrinolytic and Endothelial Variables in Normal Pregnancies and Preeclampsia. Br. J. Obstet. Gynaecol. 1994; 101: 488–492
- Yasumizu T., Kato J. Clinical Evaluation of Plasma Fibronectin Level as a Biomarker of Preeclampsia. J. Obstet. Gynaecol. Res. 1996; 22(3)221–227
- Deng L., Bremme K., Hansson L.-O., Blombäck M. Plasma Levels of von Willebrand Factor and Fibronectin as Markers of Persisting Endothelial Damage in Preeclampsia. Obstet. Gynecol. 1994; 84(6)941–945
- Paternoster D. M., Stella A., Simioni P., Girolami A., Plebani M. Fibronectin and Antithrombin as Markers of Pre-eclampsia in Pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 70: 33–39
- Martin J. N., May W. L., Magann E. F., Terrone D. A., Rinehart B. K., Blake P. G. Early Risk Assessment of Severe Preeclampsia; Admission Battery of Symptoms and Laboratory Tests to Predict Likelihood of Subsequent Significant Maternal Morbidity. Am. J. Obstet. Gynecol. 1999; 180(6)1407–1414
- He S., Bremme K., Blombäck M. Acquired Deficiency of Antithrombin in Association with a Hypercoagulable State and Impaired Function of Liver and/or Kidney in Preeclampsia. Blood Coagul. Fibrinolysis 1997; 8: 232–238
- Taylor R. N., Crombleholme W. R., Friedman S. A., Jones L. A., Casal D. C., Roberts J. M. High Plasma Cellular Fibronectin Levels Correlate with Biochemical and Clinical Features of Preeclampsia But Cannot Be Attributed to Hypertension Alone. Am. J. Obstet. Gynecol. 1991; 165: 895–901
- Redman C. W.G., Sacks G. P., Sargent I. L. Preeclampsia: An Excessive Maternal Inflammatory Response to Pregnancy. Am. J. Obstet. Gynecol. 1999; 180(2)499–505